GlobeNewswire by notified

CoinShares confirms robust financial health and quantifies limited exposure to the FTX Exchange

Share

CoinShares has significantly reduced its exposure to FTX over the past week to approximately £26.6M. The Group's financial health remains solid despite its remaining exposure to FTX, with £240.6M net asset value as at 30 September 2022. XBT Provider and CoinShares Physical ETPs remain fully hedged and collateralized. 

10 November 2022 | SAINT HELIER, Jersey | CoinShares International Limited (Nasdaq First North Growth Market: CS; US OTCQX: CNSRF) (“CoinShares'' or the “Group”), Europe's largest and longest standing digital asset investment firm, discloses its exposure to the FTX Exchange, while confirming that the Group has no exposure to FTX’s sister company, Alameda Research. The ability to withdraw funds from FTX was halted on 8 November. 

The Group’s total exposure to FTX amounts to approximately $30.3M (£26.6M), and is comprised of: 

  • 190 BTC (approximately $3.1M) and 1,000 ETH (approximately $1.2M) in pending withdrawals which were submitted prior to the halting of withdrawals by FTX;  
  • approximately $25.9M of USD and USDC; 
  • approximately $110k of other assets.

The above represent proprietary assets of the Group, and XBT and CoinShares Physical noteholders would remain unaffected in the event that they were not recoverable. Noteholders may at any time access the Armanino TrustExplorer Attestation reports (CoinShares Physicals and XBT Provider), which are published daily.

CoinShares CEO, Jean Marie Mognetti stated, “In light of the high level of public scrutiny over the financial position of FTX  and in the spirit of transparency, we have decided to disclose our current exposure to FTX. Thanks to our prudent approach to risk, we had materially reduced our exposure to  FTX exchange in response to increased volatility and uncertainty, ahead of FTX’s decision to freeze further withdrawals. 

The financial health of the Group remains strong. As recently announced in the Group’s recent earnings results, CoinShares’ net asset value as at 30 September 2022 stood at £240.6M”. 

ABOUT COINSHARES

CoinShares is a leading full-service digital asset investment and trading group that delivers a broad range of financial services across investment management, trading, securities, and consumer products to a wide array of clients that includes corporations, financial institutions, and individuals. The Group is headquartered in Jersey, with a presence in France, Sweden, the UK, and the US. CoinShares is regulated in Jersey by the Jersey Financial Services Commission, in France by the Autorité des marchés financiers, and in the US by the Financial Industry Regulatory Authority. CoinShares is publicly listed on the Nasdaq First North Growth Market under the ticker CS and the OTCQX under the ticker CNSRF.

For more information on CoinShares, please visit: https://coinshares.com
Company  | +44 (0)1534 513 100 | enquiries@coinshares.com 
Investor Relations  | +44 (0)1534 513 100 | enquiries@coinshares.com 
Certified Advisor – Mangold Fondkommission AB  | +46 (0)8 503 015 50 | ca@mangold.se


PRESS CONTACT

CoinShares
Benoît Pellevoizin
bpellevoizin@coinshares.com

H-Advisors Maitland
Freddie Barber / Alasdair Todd
coinshares@h-advisors.global
+44 (0) 207 379 5151

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Lumina Datamatics Acquires UK-based Sunrise Setting Ltd.8.12.2022 20:15:35 CET | Press release

MILTON KEYNES, United Kingdom, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Lumina Datamatics UK Ltd. signed a definitive agreement to acquire a controlling stake in UK-based Sunrise Setting Ltd., a boutique company based in Brixham, UK, supporting academic and other publishers including non-publisher organizations to produce more than 500 publications each year. “The acquisition of Sunrise Setting Ltd. deepens our commitment to our current customers, and also fits with our strategic growth plan. Sunrise Setting Ltd.’s customers will benefit greatly from our broad range of publishing and technology solutions. The depth and experience of Sunrise Setting Ltd. will enhance Lumina Datamatics’ presence in the UK and EU regions and will help us gain a competitive advantage in the publishing space,” said Sameer Kanodia, Managing Director & CEO of Lumina Datamatics. “There is clear alignment with our company offerings and we are looking forward to taking advantage of the synergies resulting from our coll

BioGX Launches 'pixl™' Portable qPCR Platform Ex-US With Expanded Test Menu for Infectious Diseases8.12.2022 20:00:00 CET | Press release

BIRMINGHAM, Ala., Dec. 08, 2022 (GLOBE NEWSWIRE) -- BioGX, a global provider of easy molecular diagnostic solutions since 2007, announced the Ex-US commercial release of its portable pixl™ qPCR real-time PCR platform for use with BioGX CE-IVD marked assays, enabling global access and complementing the recent US FDA EUA expanded use of Xfree™ COVID-19 Direct RT-PCR on the pixl. The pixl instrument is a benchtop 4-channel, 16-well, RT-PCR instrument that supports rapid turnaround times for batches of up to 16 samples, with integrated results interpretation on a device with the compact footprint of a touchpad. "pixl, combined with our unique Xfree chemistry, offers a low-cost direct-sample-to-answer PCR solution on a portable, compact device. pixl will provide broader access to clinical laboratories for decentralized PCR testing, enabling faster, better, low-cost near-patient molecular diagnostics," said Shazi Iqbal, Ph.D., CEO of BioGX. This platform was previously CE-IVD marked and can

Notification under Chapter 9, Section 10 of the Finnish Securities Market Act: holdings of The Goldman Sachs Group, Inc. in Nokia Corporation exceeded 5%8.12.2022 19:00:00 CET | Press release

Notification under Chapter 9, Section 10 of the Finnish Securities Market Act: holdings of The Goldman Sachs Group, Inc. in Nokia Corporation exceeded 5% Nokia Corporation Stock Exchange Release 8 December 2022 at 20:00 EET Notification under Chapter 9, Section 10 of the Finnish Securities Market Act: holdings of The Goldman Sachs Group, Inc. in Nokia Corporation exceeded 5% According to a notification received under Chapter 9, Section 5 of the Finnish Securities Market Act (FSMA) by Nokia Corporation, the direct and indirect holdings of The Goldman Sachs Group, Inc. in Nokia have on 2 December 2022 exceeded 5% of the total number of shares and voting rights of Nokia. According to the notification received by Nokia, the holdings of The Goldman Sachs Group, Inc. in Nokia on 2 December 2022, directly and through its controlled undertakings and funds was equivalent to a total of 293,966,891 shares, corresponding to approximately 5.22% of the total number of shares and voting rights of Nok

Grant of Warrants8.12.2022 18:47:01 CET | Press release

December8, 2022 Announcement no. 18 Grant of Warrants COPENHAGEN, DENMARK and BOSTON, MA, USA, December 8, 2022, (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (BioPorto or Company) (CPH:BIOPOR) has, in accordance with its current authorization to issue warrants to key employees of BioPorto, today issued 1,200,000 warrants for the subscription of an equal number of shares. The warrants are issued in accordance with the Company’s remuneration policy and the authorization in section 18 a of the Articles of Association. Each warrant grants the holder the right to subscribe for one share in BioPorto. The exercise price is DKK 2.55 per share, corresponding to the closing price today on Nasdaq Copenhagen. The warrants vest over a four-year period. The warrants include conditions on claw-back in case of e.g., erroneous financial information and provisions on accelerated vesting in case of e.g., a takeover bid and/or business combinations. Detailed terms of the new and existing warr

Volta Finance Limited - Dividend Declaration8.12.2022 18:15:00 CET | Press release

Volta FinanceLimited (VTA/VTAS) Dividend Declaration NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES Guernsey, 8 December 2022 Volta Finance Limited ("the Company") hereby announces a fourth interim dividend for the financial year commencing 1 August 2021. The Company announces that it has declared a quarterly interim dividend of €0.12 per share payable on 26 January 2023 amounting to approximately €4.42 million, equating approximately to an annualised 8% of net asset value. The ex-dividend date is 29 December 2022 with a record date of 30 December 2022. The Company has arranged for its shareholders to be able to elect to receive their dividends in either Euros or Pounds Sterling. Shareholders will, by default, receive their dividends in Euros, unless they have instructed the Company’s Registrar, Computershare Investor Services (Guernsey) Limited (“Computershare”), to pay dividends in Pounds Sterling. Such instructions may be given to Com